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Abstract 9 
Background: The association between disease and socioeconomic position (SEP) is well 10 
established. Allostatic load (AL), or physiological ‘wear and tear’, is a concept that aims to 11 
elucidate the biological consequences of stress that may underlie these associations. The 12 
primary objective of this paper is to review the biomarkers and methods used to operational-13 
ise the concept of AL in studies analysing the association between AL and SEP. 14 
 15 
Methods: Four databases (Embase, Global Health, MEDLINE, and PsychINFO) were 16 
searched using terms related to AL, biomarkers and SEP. Data extraction focused on the 17 
methods used to calculate AL indices. The frequency of pair-wise combinations of bi-18 
omarkers were used to assess the level of overlap in AL definition between studies. 19 
 20 
Results: Twenty-six studies analysing the association between AL and SEP were included. 21 
There was no consistent method of operationalising AL across studies. Individual biomarkers 22 
and biological systems included in the AL index differed widely across studies, as did the 23 
method of calculating the AL index. All studies included at least one cardiovascular- and 24 
metabolic-related biomarker in AL indices, while only half of studies included at least one hy-25 
pothalamic-pituitary-adrenal (HPA) axis biomarker and approximately one third an immune 26 
response-related biomarker. All but three studies found evidence of an association between 27 
lower SEP and higher AL.  28 
 29 
Conclusions: Many studies lacked fidelity to the original concept of AL in which stress was 30 
considered central. The considerable variation in biomarkers used makes studies in this re-31 
view difficult to compare. A more critical approach should be taken in the calculation of AL 32 
indices in particular to how far it captures the biological effects of psychosocial stress that 33 
may underlie socioeconomic differences in health.  34 
  35 
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Introduction  36 
The social underpinnings of disease have been long acknowledged and an extensive body 37 
of literature has linked lower socioeconomic position (SEP) with adverse health outcomes.1–3 38 
The underlying mechanism for some diseases is better understood than others. For 39 
example, it is well established that in high income countries those of a lower SEP are more 40 
likely to smoke, be hypertensive and have increased cholesterol, which in turn results in an 41 
increased risk of cardiovascular disease (CVD) events.4–7 However, the extent to which 42 
stress plays a role in the specific mechanisms through which social factors influence disease 43 
has remained elusive. Two key areas of research have emerged: one focused on how stress 44 
is related to behavioral mechanisms of disease and the other on the biological mechanisms 45 
responsible for translating stress into disease.8–11 The latter has emphasized understanding 46 
how the body internalizes an external stressor on a physiological level and how well a 47 
person can adapt to changes in his or her environment. Allostasis is a concept describing 48 
the normal process of how the human body adapts in response to a given stimulus.12 49 
Allostatic load (AL) is defined as the physiological “wear and tear” a person experiences 50 
across his or her life, for instance chronically elevated blood pressure resulting from a 51 
lifetime of occupational strain.13  52 
According to the original AL framework, stress hormones controlled by the hypothalamic-53 
pituitary-adrenal (HPA) axis (e.g. cortisol, epinephrine, and norepinephrine) are the “primary 54 
mediators” of AL, which in turn mediate “secondary effectors” such as blood pressure, lipid 55 
metabolism, and inflammation.13,14 Poor health conditions resulting from extreme values of 56 
primary mediators and secondary effectors are “tertiary outcomes” (e.g. coronary heart 57 
disease, decreased physical capacity, obesity or severe cognitive decline).15–17 In the first 58 
study to calculate an AL index, measurements of 10 biomarkers were combined from three 59 
biological domains (cardiovascular and metabolic systems, and HPA axis).18 For clarity, in 60 
this paper AL index refers to the quantifiable variable, while allostatic load refers to the 61 
conceptual framework devised by McEwen & Stellar.13  62 
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Since the term allostatic load was first introduced in 1993, the number of studies on AL have 63 
grown considerably. Between 2010 and 2017 the number of papers in PubMed mentioning 64 
AL have more than tripled, with 110 studies published in 2016 alone.19 However, researchers 65 
have not taken a consistent approach to the way they have operationalised the concept. If 66 
AL is intended to measure the physiological response to stress, then the inclusion of primary 67 
mediators, such as HPA axis biomarkers (or equivalent), in an AL index is intrinsic to its 68 
definition. 69 
These methodological inconsistencies make comparisons across studies challenging. There 70 
is therefore a need to determine how researchers define AL in the literature and to see how 71 
different definitions affect associations between stress, AL, and disease. No prior study has 72 
quantified the heterogeneity in AL indices. Previous reviews of AL, health disparities and 73 
outcomes have been performed, but none had a methodological focus, although some 74 
attention has been given to comparing different methods for how levels of constituent 75 
biomarkers should be arithmetically combined into a single index.15,20–24  76 
In this systematic review we have aimed to provide a comprehensive overview and discussion 77 
of the biomarker content and methods used to calculate AL in studies that have looked at its 78 
association with SEP. A secondary aim was to describe the associations of AL with SEP. 79 
Methods 80 
Search Strategy & Data Extraction 81 
The scope of this review was limited to the biological internalization of SEP and the effects of 82 
this stressor on AL, highlighting AL as a mechanism on the causal pathway between SEP 83 
and health outcomes (Fig 1).  84 
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FIGURE 1 HERE 85 
The literature review was restricted to peer-reviewed publications of human population 86 
studies that calculated an AL index and analysed the association between SEP as the main 87 
exposure and AL as the main outcome. Reviews, protocols, conference abstracts, and 88 
theoretical discussions were excluded. We sought to find all studies including the phrase 89 
“allostatic load”, “biomarker”, and SEP. Specific search terms can be found in Appendix A. 90 
Five electronic databases were searched (Embase, Global Health, MEDLINE, and 91 
PsychINFO) to identify articles published up to July 7th 2017, with no language restrictions. 92 
Additionally, previous reviews of AL and social factors were cross-referenced to check the 93 
sensitivity of the search strategy.22–24 The preferred reporting items for systematic reviews 94 
and meta-analyses (PRISMA) guidelines were followed with a focus on methodologies used 95 
to operationalise AL.25  96 
Analyses 97 
We reviewed the biomarkers included in AL indices according to biological system, as 98 
defined by the study, and then looked at the frequency of papers in which each biomarker 99 
was included. Biomarkers that were measured differently were included as separate 100 
biomarkers; for instance, fasting glucose measures and non-fasting glucose measures were 101 
categorised as two separate biomarkers. A sensitivity analysis was also performed, where 102 
closely related biomarkers with minor differences were collapsed into one biomarker.  103 
We quantified the extent to which papers used the same set of biomarkers in their AL index 104 
using a pair-wise approach in which the biomarker set of each study was compared to that of 105 
every other study. For every pair-wise comparison we counted the number of biomarkers 106 
that they used in common. This could vary between zero and total number of discrete 107 
biomarkers observed across all included papers. In addition we identified every unique 108 
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biomarker combination observed, and counted the number of studies using any unique 109 
combination. 110 
We analysed the data using MS Excel and analysed using Stata 14.1. 111 
Results  112 
Findings from the literature search  113 
The search strategy outlined above identified 282 papers; four additional papers were 114 
included from cross-referencing previous systematic reviews resulting in 287 articles 115 
screened (Fig 2). Thirty-one full text articles were reviewed after duplicate removal and title 116 
and abstract screening. Of these, five articles were excluded due to not reporting a direct 117 
measure of the association between AL and SEP, leaving a total of 26 articles. Of these 26, 118 
four analysed the National Health and Nutrition Examination Survey, three that used the 119 
Midlife in the US survey, and two that used the West of Scotland Twenty-07 study.   120 
FIGURE 2 HERE 121 
The majority of studies were cross-sectional, used US-based population datasets, had a 122 
sample size between 1000 and 10,000 observations (Table 1). See Supplementary Table S1 123 
for full data extraction. Studies identified were published between 1999 and 2016, with most 124 
appearing after 2009.  125 
TABLE 1 HERE 126 
Biomarker selection and measurement 127 
A total of 59 individual biomarkers were used in one or more studies. The number of biomarkers 128 
used to create an AL index ranged between 6 and 25 (Table 1), with a mode of 9. There were 20 129 
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biomarker combinations observed across the 26 studies included in the literature review. 130 
Table 2 summarizes the number of studies including each biomarker organized by biological 131 
system. Biomarkers appearing in only one study are listed in Supplementary Table S2. All 132 
studies included at least one cardiovascular and one metabolic marker; the majority of 133 
studies (85%) included one immune marker, while only 58% included an HPA axis marker.  134 
TABLE 2 HERE 135 
AL indices were most often calculated by summing the number of biomarkers for which the 136 
individual was determined to be “high risk”. The majority of studies (73%) used quartile-137 
based cutoffs for individual biomarkers, and the scores for each biomarkers would then be 138 
summed (with each biomarker equally weighted). Cortisol was the only biomarker that had 139 
different cutoffs from the other biomarkers. For example, 3 studies used quartile cutoffs for 140 
all biomarkers except cortisol, where the lowest and highest octiles were considered high 141 
risk, based on previous studies associating extremely low and extremely high levels of 142 
cortisol with adverse health outcomes.26–28  143 
Rather than summing individual biomarkers, four studies summed the proportion of high risk 144 
markers by biological system.29–32 For example, if a person was above the high-risk cutoff for 145 
two out of four cardiovascular biomarkers, they would receive a score of 0.5 for this system. 146 
This approach was used in studies analysing the Midlife in the US study where over 20 147 
biomarkers were combined from five or more biological systems to calculate an AL index. 148 
 Most studies analysed AL index as a continuous outcome (e.g. a score ranging from 0-10), 149 
while others dichotomized the AL index into “high” (e.g. above three) and “low” (e.g. below or 150 
at three). Four studies included the same nine biomarkers from the immune response, 151 
cardiovascular and metabolic systems with no HPA axis biomarker.33–36 Two studies included 152 
the same 24 biomarkers from the immune response, HPA axis, and cardiovascular, 153 
metabolic, respiratory and parasympathetic nervous systems. 31,32 All remaining 20 studies 154 
used different sets of biomarkers to calculate AL. 155 
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Analysis of shared biomarkers 156 
To understand how biomarkers were shared between studies, each study (n=26) was paired 157 
with all other studies for a potential of 325 pair-wise combinations. Table 3 shows the total 158 
pairs of studies, according to the number of biomarkers the study pairs have in common. 159 
Also shown are how many pairs share distinct groups of biomarkers, referred to as unique 160 
combinations. For example, the last row of the table shows that 16 study pairs shared only 161 
one common biomarker, among which there were five unique biomarker combinations (in 162 
this case, five unique biomarkers). It was most common for two studies to share five 163 
biomarkers, with 55 pairs of studies (17% of all pairs) sharing exactly five biomarkers. 164 
Twenty-four of these pairs (44%) were unique combinations of biomarkers. Only five pairs of 165 
studies had 10 biomarkers in common, four of which (80%) were unique combinations. 166 
TABLE 3 HERE 167 
Substantial heterogeneity was observed across AL indices when comparing studies to each 168 
other. Across all the possible combinations of biomarkers shared by two studies, the most 169 
commonly shared group of biomarkers was waist to hip ratio, systolic blood pressure, 170 
diastolic blood pressure and high density lipoprotein cholesterol, which appeared in 11 pairs 171 
of studies. The other biomarkers used in these AL indices hardly overlapped and were often 172 
categorised in different biological systems. For example, one study appeared in nine of the 173 
11 pairs and additionally included biomarkers from the metabolic system and the HPA axis.37 174 
Another study appeared twice and included metabolic system-related, immune response and 175 
HPA axis markers.49 A sensitivity analysis in which closely related but distinct biomarkers 176 
(e.g. fasting and non-fasting glucose) were collapsed into fewer broader classes  (e.g. 177 
glucose) did not change our findings (see Supplementary Table S4).      178 
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Association between AL and SEP 179 
There was considerable heterogeneity in the measurement of SEP. Education, income and 180 
occupation were the most common measures, with six studies examining how changes in 181 
SEP over an individual’s lifetime were associated with AL in adulthood. Linear and logistic 182 
regression were primarily used to evaluate associations. Because of the diversity of SEP 183 
measures, analytic methods and heterogeneity in the definition and method of calculation of 184 
AL indices we did not calculate a summary measure of association between AL and SEP. 185 
Instead, a qualitative description of the strength of association was assigned based the 186 
magnitude of effect measures. However, in almost all studies lower SEP groups had higher 187 
AL indices (Table 4), while three studies found evidence of effect modification. One study 188 
found the association between AL and SEP differed by ethnicity while two others found the 189 
association differed by gender (Table 4).28,34,38 All three used different biomarkers, high-risk 190 
cut-off criteria, SEP measurement, and methods of statistical analysis from one another. See 191 
supplementary table 3 for specific effect measures.  192 
TABLE 4 HERE   193 
Discussion  194 
We reviewed the methodologies used to operationalise the concept of allostatic load, a term 195 
intended to represent the biological “wear and tear” a person experiences throughout life. 196 
Our findings indicate there is no standard method of calculating an AL index in the literature 197 
on AL and SEP. Across the 26 studies in the literature review, there were 59 biomarkers 198 
combined in 20 different ways. Not only were studies dissimilar to one another, there was no 199 
study that used the same biomarkers as the original calculation of an AL index using the 200 
MacArthur study.18 Additionally, fewer than 60% of studies included an HPA axis-related 201 
biomarker, a key component of the conceptual framework devised by Stellar & McEwen.13 202 
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Lastly, all but three studies found a negative association between AL and SEP, such that 203 
SEP decreased as AL increased.  204 
Whether or not a biomarker was included in AL indices appeared to be dependent on which 205 
biomarkers were collected. Papers analysing the MIDUS study, for example, all included 206 
HPA-axis related biomarkers whereas none of the studies analysing the NHANES included 207 
such markers. The MIDUS study was designed to explore the psychosocial factors affecting 208 
health outcomes in ageing Americans and contained an extensive biomarker profile whereas 209 
the NHANES was focused on nutritional status and disease. Not all studies are equally well 210 
suited for calculating an AL index, however, many studies appropriated the term AL 211 
regardless of how closely their index matched with the original conceptual framework. 212 
The substantial inconsistency in biomarkers used to operationalise AL and the lack of fidelity 213 
to its original conception as an index that captures the biological response to psychosocial 214 
stress is striking. This suggests that the empirical literature on AL is intrinsically flawed and 215 
without a strong conceptual basis. Cardiovascular- and metabolic-related markers were not 216 
only ubiquitous in AL definitions, but were also overrepresented in many studies relative to 217 
other biological systems. It is well known that cardiovascular- and metabolic-related risk 218 
factors for CVD increase for those of a lower SEP, and these biomarkers are also more 219 
closely related to health behaviors (e.g. smoking and an increase in blood pressure).39–43 By 220 
contrast, HPA axis biomarkers were absent from nearly half of studies, which contradicts 221 
McEwen & Stellar’s initial conceptual framework emphasizing the importance of HPA axis 222 
biomarkers as primary mediators. In fact, AL is defined as the result of the “heightened 223 
neural or neuroendocrine response resulting from repeated or chronic environmental 224 
challenge”.13 Other biological systems, such as kidney/liver function, have been added into 225 
AL indices, despite not being included in this original conceptualization. This divergence 226 
makes it difficult to know what is being measured by AL, let alone interpret findings that 227 
examine the association between SEP and AL.  228 
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Despite the considerable inconsistency in AL operationalisation, the vast majority of articles 229 
reviewed found a negative association between SEP and AL. It is not expected that a 230 
reworking of the operationalisation of AL would dramatically affect these associations. 231 
Rather, the lack of coherence makes it difficult to compare findings from different studies (for 232 
example, in comparing the strength of association between AL and different SEP indicators), 233 
and therefore hinders a better understanding of the biological mechanisms underlying poorer 234 
health amongst those of a lower SEP.  235 
Strengths & limitations 236 
 237 
This is the first systemic review of the methodologies used to calculate AL indices in studies 238 
examining the relationship between AL and SEP. This undertaking is particularly important in 239 
light of the growing number of studies analysing AL in population studies. The following limi-240 
tations, however, should be considered.  241 
 242 
This review was limited to studies analysing the association between AL and SEP and did 243 
not include studies analysing AL indices as a predictor of disease outcomes. However, the 244 
issues identified here are likely to also occur in the wider literature on AL, especially if these 245 
issues are reflective of the availability of biomarkers collected in population-based studies. 246 
Since these inconsistencies in AL operationalisation are a result of biomarker inclusion, a 247 
broader review would have likely led to the same conclusion. 248 
 249 
Additionally, given the diversity of measures employed it was difficult to summarise the 250 
strength of associations observed across all studies in this review. The qualitative assess-251 
ment of the associations observed between SEP and AL are therefore meant to describe the 252 
direction of observed associations, rather than calculate a single summary estimate of the 253 
association between SEP and AL.  254 
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Future directions 255 
Consistency across methods of calculating AL indices is key for reproducibility and 256 
generalizability of findings. We suggest future research focuses on examining the relevance 257 
of individual biomarkers and biological systems in construction of AL, as supported by the AL 258 
conceptual framework and evidence relating to different pathways through which chronic 259 
stress is embodied physiologically.  260 
It is important to note that the original concept of AL is not invalidated based on problematic 261 
operationalisation. Studies following the original concept, that is including an HPA biomarker 262 
(such as those using the MIDUS study), should be regarded as the standard for using the 263 
term AL. Future studies incorporating additional biomarker measures, such as DNA 264 
methylation or telomere length, should clearly state how their analysis differs from the 265 
original concept.  266 
Efforts to translate the concept of AL into a quantifiable variable have been widespread, 267 
however, it is crucial to consolidate this information, as we have done here, to improve AL 268 
studies. By excluding the HPA axis, these studies do not contribute to our current 269 
understanding of AL.  270 
Concluding remarks 271 
In conclusion, this review identified substantial methodological inconsistencies in calculating 272 
AL indices and a clear divergence from the original conceptual framework in the literature on 273 
AL and SEP. In the nearly 20 years since AL was first operationalised, the literature has 274 
become increasingly heterogeneous in the way composite AL indices are calculated. 275 
Standardization of definitions is key for reproducibility and establishing the validity of the 276 
published literature, especially when adapting a relatively new conceptual framework to 277 
analysis in population studies. There is a clear interest in a comprehensive measure of 278 
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health that researchers can use to examine complex interactions in biological and 279 
psychosocial pathways to health. Interpreting AL and its association with SEP, however, is 280 
hindered due to the diverse nature of operational definitions. Ionnidis and colleagues have 281 
suggested that 85% of research resources are wasted, in part due to the lack of 282 
standardized definitions and reproducibility in research.44  Developing a standardized, valid 283 
method for operationalizing AL in population studies is critical in order to ensure findings 284 
from future studies are valid and reproducible. 285 
  286 
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 428 
Appendix A 429 
The following search terms were used to capture studies operationalizing AL: “allostatic load” 430 
and biomarker* or “biological marker*”. The following map search terms were used to 431 
capture studies examining SEP in relation to 5 topics based on prior literature on SEP and 432 
health.45–49 433 
Socioeconomic position: socio?economic status, socio?economic position, subjective 434 
social status, social class 435 
Education: education* 436 
Wealth: income, debt, asset*, poverty, depriv*, affluen*, financ* 437 
Employment and occupation: job, work*, umeploy*, employ* 438 
Contextual: Neighbo?rhood 439 
 440 
 441 
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Table 1. Summary characteristics of included studies analysing allostatic load in association with socioeconomic 
position 
Characteristics No. Studies (n=26) 
Study design   
Cross-sectional 15 
Longitudinal 9 
Location of study population  
US 14 
UK 2 
Sweden 1 
Nepal 1 
Denmark 1 
Canada 1 
Poland 1 
Sample size of analyses  
50-100 1 
101-500 7 
501-1000 5 
1001-10,000 10 
Over 10,000 3 
Number of biomarkers in AL index  
6-10 16 
11-15 7 
16-20 1 
21-25 3 
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Table 2. Biomarkers included in allostatic load indices by biological system. Overall there were 59 biomarkers 
representing seven biological systems.  
Biological System No. Studies (N=26) Percentage of studies 
Cardiovascular 26 100% 
Blood pressure (systolic, diastolic, hypertension) 25 96% 
Heart rate 11 42% 
Metabolic 26 100% 
HDL, low density lipoprotein (LDL), total cholesterol, 
triglycerides, apolipoproteins 24 92% 
Blood sugar (glucose, HbA1c) 23 88% 
BMI, waist circumference, WHR, percent body fat 24 92% 
Insulin 7 27% 
Immune Response 22 85% 
C-reactive protein (CRP) 20 77% 
Fibrinogen 8 31% 
Interleukin-6 (IL6) 6 23% 
Serum albumin 7 27% 
Soluble adhesion molecules 3 12% 
Tumour necrosis factor-alpha (TNF-) 3 12% 
White blood cell count 2 8% 
HPA Axis 15 58% 
Cortisol 13 50% 
Epinephrine and norepinephrine 9 35% 
DHEA-S 6 23% 
Respiratory 3 12% 
Peak expiratory flow 2 8% 
Parasympathetic Nervous System 5 19% 
Standard deviation of heartbeat to heartbeat intervals 5 19% 
Low frequency spectral power 4 15% 
High frequency spectral power 4 15% 
Root mean square of successive heartbeat differences 4 15% 
Kidney/Liver function 3 12% 
Creatinine (creatinine, creatinine clearance) 3 12% 
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Table 3. Combinations of shared biomarkers in AL between pairs of studies; sharing 11-23 biomarkers omitted. The 
denominator for the percentage was 325, which is the total number of potential pair-wise combinations for 26 studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Number of shared 
biomarkers (n=59) 
Number of pairs of 
studies [%]  
Number of unique 
combinations of 
biomarkers (n=138) 
24 1 [0.3] 1 
10 5 [1.5] 4 
9 16 [4.9] 7 
8 22 [6.8] 15 
7 33 [10.2] 15 
6 53 [16.3] 25 
5 55 [16.9] 24 
4 35 [10.8] 16 
3 25 [7.7] 11 
2 21 [6.5] 9 
1 16 [4.9] 5 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 4. Socioeconomic position measure, direction and strength of association with allostatic load. Negative 
associations indicate allostatic load increases with lower socioeconomic position. Where relevant, associations within 
subgroups is described (n=26). 
 
 
Primary Author SEP Measure Direction of Association Strength of Association 
L. D. Kubzansky37 Education Negative Strong 
B. Singer50 Household income Negative Strong 
G. Johansson51 
Career and life-course patterns, and 
occupation 
Negative 
None for life course 
pattern, strong for 
occupation 
C. M. Worthman52 Social class Negative Strong 
G. W. Evans53 Proportion of life in childhood poverty Negative Strong 
S. Stein Merkin34 
NSES, SEP: income, education, poverty, 
unemployment 
Negative   
Strong for black 
Americans, but weak for 
white and Mexican 
Americans 
C. E. Bird33 NSES Negative Strong 
L. C. Gallo26 
Financial strain, work stress, and housing 
problems 
Negative Strong 
T. L. 
Gruenewald30 
SEP in adulthood and childhood: 
education and income 
Negative 
Strongest in later 
adulthood 
D. A. Hickson38 Education, income Negative/Positive 
Strongly negative for 
women, weakly negative 
for men with less 
education, weakly 
positive for men with 
lower income 
K. P. Theall54 Individual SEP and NSES Negative Strong 
B. Rainisch55 Income and education Negative Strong 
RP Juster28 Occupational status Negative/Positive 
Strongly negative in 
women of lower 
occupational status, but 
the reverse in men 
T. Robertson36 
Social class in childhood, early 
adulthood, and adulthood 
Negative 
Strongest for early 
adulthood and childhood 
T. E. Seeman31 Social rank Negative Strong 
P. E. Gustafsson27 
NSES and neighborhood adversity 
across life course 
Negative Strong 
A.M. Hansen56 
Occupation, vocational training, 
education 
Negative 
Strong for both men and 
women 
A. Lipowicz57 Education, marital status, residence Negative Strong 
E. M. Friedman29 Early life SEP: education and income Negative Strong 
T. Robertson35 Occupational class Negative Strong 
D. M. Upchurch58 Education and income Negative Strong 
C.B. Solis59 
Maternal education and paternal 
occupation 
Negative Strong 
E. Chen60 Family economic hardship Negative Strong 
C. R. Gale61 Childhood SEP Negative Strong 
N. R. Hamdi32 Education Negative Strong 
T. Robertson62 Education Negative Strong 
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Figure 2. Flow chart of studies from literature search included in full data extraction25 
Records identified from OpenGrey, 
Embase, Medline, Global Health 
and PsychINFO  
(n = 282) 
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Additional records identified through 
review articles 
(n = 4) 
Duplicate records removed 
(n= 137) 
Records excluded (e.g. 
reviews, non-human 
studies, theoretical 
framework only, no 
measure of SEP or AL 
(n = 119) 
Full-text articles assessed 
for eligibility 
(n = 31) 
Full-text articles excluded 
if no direct measure of 
association between AL 
and SEP was reported  
(n = 5) 
Studies included 
(n = 26) 
Title and abstracts of 
records screened 
(n = 150) 
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• Allostatic load (AL) describes the biological effect of “cumulative wear and tear” 
• The AL concept is operationalised through biomarker measurement 
• AL is used to elucidate the biological basis of socioeconomic health differences  
• Definitions are inconsistent and often show poor fidelity to the original concept 
• Interpretation of AL should be subject to critical scrutiny 
